Pre-Treatment Breast MRI Features and ADC Values as Predictors of Pathologic Complete Response in Breast Cancer: A Molecular Subtype-Based Analysis
Diagnostics · 22.03.2026 · 16 (6) · 938
DOI: 10.3390/diagnostics16060938 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 22.03.2026. Verfasst von Ela Kaplan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Faculty of Medicine, Adiyaman University, Adiyaman 02040, Turkey. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: The role of pre-treatment breast magnetic resonance imaging (MRI) findings and apparent diffusion coefficient (ADC) values in predicting pathologic complete response (pCR) in breast cancer patients receiving neoadjuvant chemotherapy (NAC) has not yet been sufficiently clarified, especially in the context of molecular subtype differences. In this study, we questioned whether these imaging parameters were independent predictors of pCR.
Methods
This study retrospectively explored MRI characteristics of 188 patients who underwent NAC from 2015 to 2023. The patients were divided into the pCR-positive and pCR-negative groups—the latter comprising patients with partial response (n = 61) and stable disease (n = 90)—and were classified into four molecular subtypes: Luminal A/B, HER2-enriched, and triple-negative breast cancer (TNBC). The MRI parameters included pre-chemotherapy T2-weighted signal characteristics, shape features, contrast kinetics, peritumoral edema, and ADC MIN/ADC MAX. Post-treatment ADC and ΔADC were the post-chemotherapy MRI parameters. Independent predictors were evaluated by logistic regression and discriminant performance by ROC analysis.
Results
The overall pCR rate was 19.7%. In multivariate analysis, T2-weighted isointense signal (OR = 4.50), uniform tumor shape (OR = 12.83), HER2-enriched subtype (OR = 6.03), TNBC (OR = 5.15), ADC MIN (OR = 1.41), tumor size (OR = 1.28), and kinetic Type 3 pattern (OR = 3.21) were identified as independent predictors. Pre-treatment ADC MIN yielded an AUC of 0.724, while post-treatment ADC achieved 100% sensitivity and 96.7% specificity (AUC = 0.967).
Conclusions
MRI morphology and ADC values may make a meaningful contribution to the prediction of pCR when evaluated in the context of molecular subtype. Post-treatment ADC demonstrated particularly strong discriminatory performance; however, external validation in multicenter cohorts is required before clinical implementation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Faculty of Medicine, Adiyaman University, Adiyaman 02040, Turkey.
- Departmant of Surgery Oncology, Faculty of Medicine, Adiyaman University, Adiyaman 02040, Turkey.
- Departmant of Gynecology and Obstetrics, Faculty of Medicine, Adiyaman University, Adiyaman 02040, Turkey.
ORCID-Profile: Ela Kaplan
Zitieren
APA
Kaplan, E., Alakus, H., & Kaplan, S. (2026). Pre-Treatment Breast MRI Features and ADC Values as Predictors of Pathologic Complete Response in Breast Cancer: A Molecular Subtype-Based Analysis. Diagnostics, 16(6), 938. https://doi.org/10.3390/diagnostics16060938
Vancouver
Kaplan E, Alakus H, Kaplan S. Pre-Treatment Breast MRI Features and ADC Values as Predictors of Pathologic Complete Response in Breast Cancer: A Molecular Subtype-Based Analysis. Diagnostics. 2026;16(6):938. doi:10.3390/diagnostics16060938
BibTeX
@article{Kaplan2026,
author = {Kaplan, Ela and Alakus, Hüseyin and Kaplan, Selcuk},
title = {Pre-Treatment Breast MRI Features and ADC Values as Predictors of Pathologic Complete Response in Breast Cancer: A Molecular Subtype-Based Analysis},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {6},
pages = {938},
doi = {10.3390/diagnostics16060938}
}
EUVIMED